Corcept Therapeutics Inc (NASDAQ: CORT) is 2.49% higher on its value in year-to-date trading and has touched a low of $20.84 and a high of $35.22 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CORT stock was last observed hovering at around $33.24 in the last trading session, with the day’s gains setting it 0.05%.
Currently trading at $33.29, the stock is 7.19% and 10.50% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.91 million and changing 0.15% at the moment leaves the stock 25.61% off its SMA200. CORT registered 42.63% gain for a year compared to 6-month gain of 34.13%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 16.44% loss in the last 1 month and extending the period to 3 months gives it a 44.74%, and is 6.80% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.05% over the week and 3.53% over the month.
Corcept Therapeutics Inc (CORT) has around 352 employees, a market worth around $3.47B and $523.53M in sales. Current P/E ratio is 31.37 and Fwd P/E is 24.64. Profit margin for the company is 22.38%. Distance from 52-week low is 59.74% and -5.48% from its 52-week high. The company has generated returns on investments over the last 12 months (21.39%).
Corcept Therapeutics Inc quarterly earnings per share for the current quarter are estimated at $0.23 with sales reaching $155.23M over the same period.The EPS is expected to grow by 2.34% this year, but quarterly earnings will post 31.00% year-over-year. Quarterly sales are estimated to grow 41.50% in year-over-year returns.
The shares outstanding are 103.41M, and float is at 89.78M with Short Float at 24.38%.
Corcept Therapeutics Inc (CORT) Insider Activity
The most recent transaction is an insider sale by Robb Gary Charles, the company’s Chief Business Officer. SEC filings show that Robb Gary Charles sold 11,000 shares of the company’s common stock on Jul 01 ’24 at a price of $32.49 per share for a total of $0.36 million. Following the sale, the insider now owns 26291.0 shares.
Corcept Therapeutics Inc disclosed in a document filed with the SEC on Jul 01 ’24 that Guyer William (Chief Development Officer) sold a total of 10,000 shares of the company’s common stock. The trade occurred on Jul 01 ’24 and was made at $32.49 per share for $0.32 million. Following the transaction, the insider now directly holds 6039.0 shares of the CORT stock.
Still, SEC filings show that on Jul 01 ’24, Lyon Joseph Douglas () disposed off 5,000 shares at an average price of $32.49 for $0.16 million. The insider now directly holds 9,290 shares of Corcept Therapeutics Inc (CORT).
